Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
6.68
+0.24 (3.73%)
Aug 25, 2026, 4:00 PM EDT - Market closed
Gyre Therapeutics Employees
Gyre Therapeutics had 625 employees as of December 31, 2025. The number of employees increased by 46 or 7.94% compared to the previous year.
Employees
625
Change (1Y)
46
Growth (1Y)
7.94%
Revenue / Employee
$175,709
Profits / Employee
-$31,853
Market Cap
708.31M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 625 | 46 | 7.94% |
| Dec 31, 2024 | 579 | -14 | -2.36% |
| Dec 31, 2023 | 593 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Phathom Pharmaceuticals | 371 |
| MapLight Therapeutics | 133 |
| OmniAb | 89 |
| Prelude Therapeutics | 79 |
| Assembly Biosciences | 73 |
| Crescent Biopharma | 69 |
| CytomX Therapeutics | 69 |
| AgomAb Therapeutics NV | 62 |
GYRE News
- 18 days ago - Gyre Therapeutics Earnings release: Q2 2026 - Filings
- 18 days ago - Gyre Therapeutics Quarterly report: Q2 2026 - Filings
- 18 days ago - Gyre Therapeutics Reports Second Quarter 2026 and Year-to-Date Financial Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - Gyre Therapeutics Appoints Three New Members to its Board of Directors - GlobeNewsWire
- 6 weeks ago - Gyre Therapeutics Registration statement: Registration filing - Filings
- 2 months ago - Gyre Therapeutics Registration statement: Registration filing - Filings
- 2 months ago - Gyre Therapeutics files to sell 30.22M shares of common stock for holders - TheFly
- 2 months ago - Gyre Therapeutics Transcript: AGM 2026 - Transcripts